Back
Aviat Networks 10K Form
Sell
40
AVNW
Aviat Networks
Last Price:
$16.91
Seasonality Move:
5.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-01 | 10Q | AVNW/Aviat Networks Quarterly |
2024-02-06 | 10Q | AVNW/Aviat Networks Quarterly |
2023-11-01 | 10Q | AVNW/Aviat Networks Quarterly |
2023-05-03 | 10Q | AVNW/Aviat Networks Quarterly |
2023-02-01 | 10Q | AVNW/Aviat Networks Quarterly |
2022-11-02 | 10Q | AVNW/Aviat Networks Quarterly |
Receive AVNW News And Ratings
See the #1 stock for the next 7 days that we like better than AVNW
AVNW Financial Statistics
Sales & Book Value
Annual Sales: | $408.1M |
---|---|
Cash Flow: | $-32.6M |
Price / Cash Flow: | 12.42 |
Annual Sales: | $19.49 |
Price / Book: | 0.86 |
Profitability
EPS (TTM): | -0.31000 |
---|---|
Net Income (TTM): | $-5.1M |
Gross Margin: | $144.7M |
Return on Equity: | -2.06% |
Return on Assets: | -1.03% |
Aviat Networks Earnings Forecast
Key Aviat Networks Financial Ratios
-
The Gross Profit Margin over the past 30 years for AVNW is 35.47%.
-
The Selling, General & Administrative Expenses for AVNW have been equal to 20.84% of Gross Profit Margin.
-
The Research & Development expenses have been 8.93% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of AVNW is 2.64% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 16 years.
Aviat Networks Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Communications Equipment |
Sector: | Information Technology |
Current Symbol: | AVNW |
CUSIP: | 05366Y |
Website: | aviatnetworks.com |
Debt
Debt-to-Equity Ratio: | 0.34 |
---|---|
Current Ratio: | 1.72 |
Quick Ratio: | 1.34 |
Price-to-Earnings
Trailing P/E Ratio: | 19.58 |
---|---|
Forward P/E Ratio: | 4.72 |
AVNW Technical Analysis vs Fundamental Analysis
Sell
40
Aviat Networks (AVNW)
is a Sell
Is Aviat Networks a Buy or a Sell?
-
Aviat Networks stock is rated a SellThe current Aviat Networks [AVNW] share price is $16.84. The Score for AVNW is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.